#London #United Kingdom #Healthcare Conference #Novavax #Vaccine Technology

Novavax's Participation in the Jefferies London Healthcare Conference 2025

On November 19, 2025, Novavax, Inc. (NASDAQ: NVAX) will take part in the much-anticipated Jefferies London Healthcare Conference. This event provides an essential platform for Novavax to share its innovative strategies and advancements in vaccine technology with investors and healthcare professionals alike.

Event Details

The conference will feature a fireside chat scheduled for 4:30 PM GMT, providing attendees an opportunity to gain insights into the company's progress and future plans. For those unable to attend in person, a live webcast of the session will be accessible on Novavax's official website. After the event, a recording will be available for 30 days, ensuring that all interested parties can catch up on what was discussed.

About Novavax

Novavax, known for its cutting-edge approach to vaccine development, utilizes a sophisticated technology platform that includes protein-based nanoparticles and its proprietary Matrix-M® adjuvant. The company focuses on addressing some of the most pressing global health challenges using its scientific expertise and commitment to research and development.

Their ambitious growth strategy aims to not only optimize existing partnerships but also expand access to its technology through sustained innovation. By continually developing its portfolio, particularly in the infectious disease sector, Novavax is poised to make significant contributions to global health.

Innovations and Future Directions

At the conference, Novavax expects to highlight its achievements in vaccine development, including advancements that have resulted from its collaborations with various research institutions and pharmaceutical companies. The discussions may also include insights into their strategies for tackling persistent health issues worldwide, particularly in vaccines that target infectious diseases.

Furthermore, Novavax has been actively exploring opportunities to forge new collaborations that align with its vision of combating public health crises through innovative solutions.

Conclusion

The Jefferies London Healthcare Conference provides a valuable opportunity for Novavax to showcase its progress and reaffirm its commitment to enhancing global health outcomes through innovative vaccine technology. Stakeholders and healthcare professionals are encouraged to tune in for updates on Novavax's transformations in vaccine science and its broader implications for public health. For more information, visit Novavax's website.